Evidence map›Paper›PMID 31123752›Full record

ArticleNeuro-oncology2019

Genetic variants and cognitive functions in patients with brain tumors.

Denise D Correa, Jaya Satagopan, Axel Martin, Erica Braun, Maria Kryza-Lacombe, Kenneth Cheung, Ajay Sharma, Sofia Dimitriadoy, Kelli O'Connell, Siok Leong and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuro-oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Neurotoxicity from Old and New Radiation Treatments for Brain Tumors.International journal of molecular sciences · 2023
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profile.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Denise D CorreaDepartment of Neurology and Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Jaya SatagopanDepartment of Epidemiology and Biostatistics and Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Axel MartinDepartment of Epidemiology and Biostatistics and Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Erica BraunDepartment of Neurology and Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Maria Kryza-LacombeSan Diego State University/University of California, San Diego Joint Doctoral Program in Clinical Psychology, San Diego, California.
Kenneth CheungDepartment of Epidemiology and Biostatistics and Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Ajay SharmaDepartment of Epidemiology and Biostatistics and Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Sofia DimitriadoyDepartment of Epidemiology and Biostatistics and Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Kelli O'ConnellDepartment of Epidemiology and Biostatistics and Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Siok LeongDepartment of Epidemiology and Biostatistics and Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Sasan KarimiDepartment of Neurology and Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
John LyoDepartment of Neurology and Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Lisa M DeAngelisDepartment of Neurology and Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Irene OrlowDepartment of Epidemiology and Biostatistics and Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Memorial Sloan Kettering Cancer Center · USCornell University · USSan Diego State University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Study of exposures and biomarkers in cancer epidemiologyR01CA197402 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI SATAGOPAN, JAYA M · 2016 to 2019
$1.6M
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA197402
6 · The paper itself

Abstract

backgroundPatients with brain tumors treated with radiotherapy (RT) and chemotherapy (CT) often experience cognitive dysfunction. We reported that single nucleotide polymorphisms (SNPs) in the APOE, COMT, and BDNF genes may influence cognition in brain tumor patients. In this study, we assessed whether genes associated with late-onset Alzheimer's disease (LOAD), inflammation, cholesterol transport, dopamine and myelin regulation, and DNA repair may influence cognitive outcome in this population.

methodsOne hundred and fifty brain tumor patients treated with RT ± CT or CT alone completed a neurocognitive assessment and provided a blood sample for genotyping. We genotyped genes/SNPs in these pathways: (i) LOAD risk/inflammation/cholesterol transport, (ii) dopamine regulation, (iii) myelin regulation, (iv) DNA repair, (v) blood-brain barrier disruption, (vi) cell cycle regulation, and (vii) response to oxidative stress. White matter (WM) abnormalities were rated on brain MRIs.

resultsMultivariable linear regression analysis with Bayesian shrinkage estimation of SNP effects, adjusting for relevant demographic, disease, and treatment variables, indicated strong associations (posterior association summary [PAS] ≥ 0.95) among tests of attention, executive functions, and memory and 33 SNPs in genes involved in: LOAD/inflammation/cholesterol transport (eg, PDE7A, IL-6), dopamine regulation (eg, DRD1, COMT), myelin repair (eg, TCF4), DNA repair (eg, RAD51), cell cycle regulation (eg, SESN1), and response to oxidative stress (eg, GSTP1). The SNPs were not significantly associated with WM abnormalities.

conclusionThis novel study suggests that polymorphisms in genes involved in aging and inflammation, dopamine, myelin and cell cycle regulation, and DNA repair and response to oxidative stress may be associated with cognitive outcome in patients with brain tumors.

Indexed as

AdultAgedAged, 80 and overAntineoplastic AgentsBrain NeoplasmsCognitionCognitive DysfunctionFemaleHumansMaleMiddle AgedPolymorphism, Single NucleotideRadiotherapyYoung AdultAntineoplastic Agentsbrain tumorscognitivegenespolymorphismsSNP

Identifiers

PMID31123752
PMCPMC6784270
OpenAlexW2945968972

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.